Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results February 28, 2017 Sanofi Abandons Multiple Mid-Stage Drug Programs February 7, 2018 Ironwood Provides First Quarter 2017 Investor Update May 7, 2017
